The Daily Bolus: The Triple Agonist Showdown & Surprising GLP-1 Wins in Type 1 Diabetes
Welcome to today’s edition of The Daily Bolus! The incretin landscape is rapidly evolving into the era of the “triple agonist,” with Eli Lilly and […]
Daily Bolus
The Daily Bolus: Red Cell Sponges, Microbiome Signatures, and Cyborg Cells
Today’s research is moving beyond the traditional “big three” of glucose disposal—liver, muscle, and fat. We explore how red blood cells can be recruited as metabolic “sponges,” how AI-driven gut signatures are catching insulin resistance earlier than ever, and why an electronic “cyborg” mesh might be the key to making lab-grown pancreatic cells finally function like the real thing. It’s a steady shift toward an integrated, multi-system approach to metabolic health.
The Daily Bolus: Retinopathy Pills, Diabetes Risk Watches, and Immune Fixes for Insulin Resistance
The diabetes pipeline is starting to look a lot like the cardiovascular playbook: prevent early, intervene earlier, and push treatment upstream before irreversible damage begins. […]
The Daily Bolus: Early Warnings, Genetic Cloaks, and the Seven-Year Shield
Whilst the title of this edition sounds like something out of science fiction, in it we see a masterclass in “biological intelligence.” As of February […]
The Daily Bolus: Mechanism over metrics, biology over dashboards
The developments highlighted in the bolus today reinforce a theme Diabettech has been circling for years: the most meaningful progress in diabetes does not come […]
The Daily Bolus: Et tu, B Cells?
Recent news has been defined by a pivot toward “biological intelligence.” As of January 21, 2026, the signal cutting through the noise isn’t just about […]
The Daily Bolus: What happened over the weekend?
The Daily Bolus The weekend news has produced a rare mix of genuinely interesting diabetes science alongside the usual commercial background noise. Notably, some of […]
The Daily Bolus: Interoperability, AI, and Enhanced Glycemic Insights
The past 24 hours have continued to underscore the relentless pace of innovation within diabetes technology and research, presenting clinicians and individuals living […]